Copanlisib Approved for Follicular Lymphoma

FDA has granted accelerated approval to copanlisib (Aliquopa®) for the treatment of patients with follicular lymphoma, a form of non-Hodgkin lymphoma.

http://ift.tt/2xJ2yMV